Mitsubishi Tanabe licenses simulation tech
Mitsubishi Tanabe has joined the Simcyp Consortium – gaining a license to the modeling and simulation group’s pharmacokinetic prediction technology.
Archives for July 20, 2016
GSK to expand recall of antibiotics made at Worthing API unit
GSK will recall more antibiotics made at a UK API unit that has been offline since the US FDA raised contamination concerns last year.
PPD awarded for innovative eTMF development
Pharmaceutical Product Development (PPD) has won the 2016 OpenText Elite Award for the Most Innovative Project in the Health Sciences Sector.
Patheon will list on NYSE today
API and drug maker Patheon will begin trading on the New York Stock Exchange under the symbol PTHN later today.
EMA proposes changes to Ph I guidelines after fatal BIA 10-2474 trial
European authorities want to revise the guidelines covering first-in-human studies in light of the French trial in which one man died and others were hospitalised earlier this year.
The patent lives in Hospira v MedCo: good news for CMOs
The Medicines Company announced last week that its Angiomax patent has been upheld – an 'important court decision' which affirms that working with CMOs won’t invalidate a company's patent.
update
US investor buys J&J's opiate API business and announces restructuring
SK Capital has rejigged the senior teams at opiate API maker Noramco and raw material supplier Tasmanian Alkaloids just weeks after buying the firms from Johnson & Johnson (J&J).